Pay in 4 interest-free payments of $6.32 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
The successful synthesis of ASP-BBR-PM@HNK was validated through a comprehensive series of characterization techniques, and its dual targeting capabilities, along with its anti-HCC efficacy, were assessed using both in vivo and in vitro experimental approaches
These are laboratory findings, not human treatment claims
Hierarchical activation of compartmentalized pools of AMPK depends on severity of nutrient or energy stress
Phase 2 (Jastreboff et al., NEJM 2023) reported 24.2% weight loss at 48 weeks at 12 mg
Jumpstart your treatment journey by completing our virtual planning tool
WADA status: As of the 2026 WADA Prohibited List, BPC-157 is classified under S0: Non-Approved Substances, prohibited in-competition and out-of-competition at all times
US$ 26.29
US$ 21.83
US$ 24.77
US$ 26.08
US$ 26.26
